| HOME >> BIOLOGY >> TECHNOLOGY |
------------ ------------
Loss before the undernoted (16,376,952) (14,559,302)
------------ ------------
Interest income 893,142 857,595
Interest expense (195,753) (182,440)
Loss on sale of property and equipment (1,483) (16,802)
Write down of property and equipment - (161,732)
Foreign exchange gain (loss) 262,369 (64,405)
------------ ------------
958,275 432,216
------------ ------------
Net loss and comprehensive loss for the year (15,418,677) (14,127,086)
Deficit - Beginning of year (40,740,486) (26,613,400)
------------ ------------
Deficit - End of year (56,159,163) (40,740,486)
------------ ------------
------------ ------------
Loss per share - basic and diluted (0.71) (0.85)
------------ ------------
------------ ------------
Weighted average shares outstanding 21,823,242 16,699,653
------------ ------------
------------ ------------
SemBioSys Genetics Inc.
Consolidated Statements of Cash Flows
For the years ended December 31,
----------------------------
'/>"/>
| SOURCE SemBioSys Genetics Inc. Copyright©2008 PR Newswire. All rights reserved |